Table I.
Clinicopathologic characteristics of the patients.
| Clinical parameters | Patients n=9 (100%) |
|---|---|
| Sex | |
| Female | 9 (100) |
| Age | |
| >50 | 6 (66.6) |
| ≤50 | 3 (33.3) |
| ECOG status | |
| 0-2 | 9 (100) |
| 3-4 | 0 (0) |
| Histopathology | |
| Infiltrating ductal carcinoma | 5 (55.5) |
| Classic lobular carcinoma | 1 (11.1) |
| Non-specific infiltrative | 2 (22.2) |
| Canalicular carcinoma | 1 (11.1) |
| Molecular subtype | |
| Luminal A | 5 (55.5) |
| Luminal B | 2 (22.2) |
| Triple negative | 2 (22.2) |
| Treatment | |
| Hormonotherapy | 4 (44.4) |
| Chemotherapy | 5 (55.5) |
| Metastatic | |
| Liver | 2 (22.2) |
| Lung | 3 (33.3) |
| Bones | 2 (22.2) |
| Cervical Ganglia | 5 (55.5) |
| Axillary Ganglia | 1 (11.1) |
| Mediastinum | 4 (44.4) |
| Response to systemic treatments | |
| Complete response | 2 (22.2) |
| Partial response | 2 (22.2) |
| Stable disease | 4 (44.4) |
| Progression | 1 (11.1) |